Showing results (121-130 of 133) with videos related to
Sort By:
Pageof 14
Journal of Cellular Physiology|May 11, 2017
Antitumoral potential, antioxidant activity and carotenoid content of two Southern Italy tomato cultivars extracts: San Marzano and CorbarinoDaniela Barone, Letizia Cito, Giuseppina Tommonaro, et al.Journal of Cellular Physiology|May 13, 2016
Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New DrugsAnnamaria Cimini, Michele d'Angelo, Elisabetta Benedetti, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|December 17, 2018
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody-Drug ConjugatesFrancesco Giansanti, Emily Capone, Sara Ponziani, et al.Nanoscale|March 9, 2016
Supramolecular self-assembly of graphene oxide and metal nanoparticles into stacked multilayers by means of a multitasking protein ringMatteo Ardini, Giordana Golia, Paolo Passaretti, et al.Oncotarget|October 31, 2015
Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modellingLaura Brandolini, Loredana Cristiano, Alessia Fidoamore, et al.Oncotarget|November 6, 2015
Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor modelElisabetta Benedetti, Andrea Antonosante, Michele d'Angelo, et al.Plos One|June 9, 2017
Effects of PPARα inhibition in head and neck paraganglioma cellsRosalba Florio, Laura De Lellis, Viviana di Giacomo, et al.Journal of Cellular Physiology|October 14, 2016
PPARα Antagonist AA452 Triggers Metabolic Reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary CellsElisabetta Benedetti, Michele d'Angelo, Alessandra Ammazzalorso, et al.Journal of Cellular Physiology|September 24, 2017
Targeted therapy of human glioblastoma via delivery of a toxin through a peptide directed to cell surface nucleolinAnne-Chloé Dhez, Elisabetta Benedetti, Andrea Antonosante, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 11, 2023
Ketoprofen, lysine and gabapentin co-crystal magnifies synergistic efficacy and tolerability of the constituent drugs: Pre-clinical evidences towards an innovative therapeutic approach for neuroinflammatory painAndrea Aramini, Gianluca Bianchini, Samuele Lillini, et al.Pageof 14